Modeling pre-existing immunity to adenovirus in rodents: Immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine

Jin Huk Choi, Stephen C. Schafer, Lihong Zhang, Terry Juelich, Alexander Freiberg, Maria A. Croyle

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Pre-existing immunity (PEI) to human adenovirus serotype 5 (Ad5) worldwide is the primary limitation to routine clinical use of Ad5-based vectors in immunization platforms. Using systemic and mucosal PEI induction models in rodents (mice and guinea pigs), we assessed the influence of PEI on the type of adaptive immune response elicited by an Ad5-based vaccine for Ebola with respect to immunization route. Splenocytes isolated from vaccinated animals revealed that immunization by the same route in which PEI was induced significantly compromised Ebola Zaire glycoprotein (ZGP)-specific IFN-γ+ CD8+ T cells and ZGP-specific multifunctional CD8+ T cell populations. ZGP-specific IgG1 antibody levels were also significantly reduced and a sharp increase in serum anti-Ad5 neutralizing antibody (NAB) titers were noted following immunization. These immune parameters correlated with poor survival after lethal challenge with rodent-adapted Ebola Zaire virus (ZEBOV). Although the number of IFN-γ+ CD8+ T cells was reduced in animals given the vaccine by a different route from that used for PEI induction, the multifunctional CD8+ T cell response was not compromised. Survival rates in these groups were higher than when PEI was induced by the same route as immunization. These results suggest that antigen-specific multifunctional CD8+ T cell and Th2 type antibody responses compromised by PEI to Ad5 are required for protection from Ebola. They also illustrate that methods for induction of PEI used in preclinical studies must be carefully evaluated for successful development of novel Ad5-based vaccines.

Original languageEnglish (US)
Pages (from-to)3342-3355
Number of pages14
JournalMolecular Pharmaceutics
Volume10
Issue number9
DOIs
StatePublished - Sep 3 2013

Fingerprint

Ebola Vaccines
Adenoviridae
Immunity
Rodentia
Immunization
Democratic Republic of the Congo
T-Lymphocytes
Glycoproteins
Vaccines
Ebolavirus
Human Adenoviruses
Serogroup
Adaptive Immunity
Neutralizing Antibodies
Antibody Formation
Guinea Pigs
Immunoglobulin G

Keywords

  • adenovirus serotype 5
  • guinea pig
  • mouse
  • multifunctional CD8+ T cell response
  • Pre-existing immunity
  • vaccine
  • Zaire Ebola virus

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Molecular Medicine
  • Drug Discovery

Cite this

Modeling pre-existing immunity to adenovirus in rodents : Immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine. / Choi, Jin Huk; Schafer, Stephen C.; Zhang, Lihong; Juelich, Terry; Freiberg, Alexander; Croyle, Maria A.

In: Molecular Pharmaceutics, Vol. 10, No. 9, 03.09.2013, p. 3342-3355.

Research output: Contribution to journalArticle

@article{11288aa68703420a8b3c059d18166315,
title = "Modeling pre-existing immunity to adenovirus in rodents: Immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine",
abstract = "Pre-existing immunity (PEI) to human adenovirus serotype 5 (Ad5) worldwide is the primary limitation to routine clinical use of Ad5-based vectors in immunization platforms. Using systemic and mucosal PEI induction models in rodents (mice and guinea pigs), we assessed the influence of PEI on the type of adaptive immune response elicited by an Ad5-based vaccine for Ebola with respect to immunization route. Splenocytes isolated from vaccinated animals revealed that immunization by the same route in which PEI was induced significantly compromised Ebola Zaire glycoprotein (ZGP)-specific IFN-γ+ CD8+ T cells and ZGP-specific multifunctional CD8+ T cell populations. ZGP-specific IgG1 antibody levels were also significantly reduced and a sharp increase in serum anti-Ad5 neutralizing antibody (NAB) titers were noted following immunization. These immune parameters correlated with poor survival after lethal challenge with rodent-adapted Ebola Zaire virus (ZEBOV). Although the number of IFN-γ+ CD8+ T cells was reduced in animals given the vaccine by a different route from that used for PEI induction, the multifunctional CD8+ T cell response was not compromised. Survival rates in these groups were higher than when PEI was induced by the same route as immunization. These results suggest that antigen-specific multifunctional CD8+ T cell and Th2 type antibody responses compromised by PEI to Ad5 are required for protection from Ebola. They also illustrate that methods for induction of PEI used in preclinical studies must be carefully evaluated for successful development of novel Ad5-based vaccines.",
keywords = "adenovirus serotype 5, guinea pig, mouse, multifunctional CD8+ T cell response, Pre-existing immunity, vaccine, Zaire Ebola virus",
author = "Choi, {Jin Huk} and Schafer, {Stephen C.} and Lihong Zhang and Terry Juelich and Alexander Freiberg and Croyle, {Maria A.}",
year = "2013",
month = "9",
day = "3",
doi = "10.1021/mp4001316",
language = "English (US)",
volume = "10",
pages = "3342--3355",
journal = "Molecular Pharmaceutics",
issn = "1543-8384",
publisher = "American Chemical Society",
number = "9",

}

TY - JOUR

T1 - Modeling pre-existing immunity to adenovirus in rodents

T2 - Immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine

AU - Choi, Jin Huk

AU - Schafer, Stephen C.

AU - Zhang, Lihong

AU - Juelich, Terry

AU - Freiberg, Alexander

AU - Croyle, Maria A.

PY - 2013/9/3

Y1 - 2013/9/3

N2 - Pre-existing immunity (PEI) to human adenovirus serotype 5 (Ad5) worldwide is the primary limitation to routine clinical use of Ad5-based vectors in immunization platforms. Using systemic and mucosal PEI induction models in rodents (mice and guinea pigs), we assessed the influence of PEI on the type of adaptive immune response elicited by an Ad5-based vaccine for Ebola with respect to immunization route. Splenocytes isolated from vaccinated animals revealed that immunization by the same route in which PEI was induced significantly compromised Ebola Zaire glycoprotein (ZGP)-specific IFN-γ+ CD8+ T cells and ZGP-specific multifunctional CD8+ T cell populations. ZGP-specific IgG1 antibody levels were also significantly reduced and a sharp increase in serum anti-Ad5 neutralizing antibody (NAB) titers were noted following immunization. These immune parameters correlated with poor survival after lethal challenge with rodent-adapted Ebola Zaire virus (ZEBOV). Although the number of IFN-γ+ CD8+ T cells was reduced in animals given the vaccine by a different route from that used for PEI induction, the multifunctional CD8+ T cell response was not compromised. Survival rates in these groups were higher than when PEI was induced by the same route as immunization. These results suggest that antigen-specific multifunctional CD8+ T cell and Th2 type antibody responses compromised by PEI to Ad5 are required for protection from Ebola. They also illustrate that methods for induction of PEI used in preclinical studies must be carefully evaluated for successful development of novel Ad5-based vaccines.

AB - Pre-existing immunity (PEI) to human adenovirus serotype 5 (Ad5) worldwide is the primary limitation to routine clinical use of Ad5-based vectors in immunization platforms. Using systemic and mucosal PEI induction models in rodents (mice and guinea pigs), we assessed the influence of PEI on the type of adaptive immune response elicited by an Ad5-based vaccine for Ebola with respect to immunization route. Splenocytes isolated from vaccinated animals revealed that immunization by the same route in which PEI was induced significantly compromised Ebola Zaire glycoprotein (ZGP)-specific IFN-γ+ CD8+ T cells and ZGP-specific multifunctional CD8+ T cell populations. ZGP-specific IgG1 antibody levels were also significantly reduced and a sharp increase in serum anti-Ad5 neutralizing antibody (NAB) titers were noted following immunization. These immune parameters correlated with poor survival after lethal challenge with rodent-adapted Ebola Zaire virus (ZEBOV). Although the number of IFN-γ+ CD8+ T cells was reduced in animals given the vaccine by a different route from that used for PEI induction, the multifunctional CD8+ T cell response was not compromised. Survival rates in these groups were higher than when PEI was induced by the same route as immunization. These results suggest that antigen-specific multifunctional CD8+ T cell and Th2 type antibody responses compromised by PEI to Ad5 are required for protection from Ebola. They also illustrate that methods for induction of PEI used in preclinical studies must be carefully evaluated for successful development of novel Ad5-based vaccines.

KW - adenovirus serotype 5

KW - guinea pig

KW - mouse

KW - multifunctional CD8+ T cell response

KW - Pre-existing immunity

KW - vaccine

KW - Zaire Ebola virus

UR - http://www.scopus.com/inward/record.url?scp=84883587834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883587834&partnerID=8YFLogxK

U2 - 10.1021/mp4001316

DO - 10.1021/mp4001316

M3 - Article

C2 - 23915419

AN - SCOPUS:84883587834

VL - 10

SP - 3342

EP - 3355

JO - Molecular Pharmaceutics

JF - Molecular Pharmaceutics

SN - 1543-8384

IS - 9

ER -